Alcohol septal ablation in hypertrophic cardiomyopathy: For which patients?

Percutaneous and surgical therapies for septal reduction for hypertrophic cardiomyopathy have been going head‐to‐head for the past 20 years with similar outcomes and mortality rates, although contemporary myectomy seems to materialize its superiority. However, on closer analysis, the external validi...

Descripción completa

Detalles Bibliográficos
Autores principales: Achim, Alexandru, Serban, Adela Mihaela, Mot, Stefan Dan Cezar, Leibundgut, Gregor, Marc, Madalin, Sigwart, Ulrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192292/
https://www.ncbi.nlm.nih.gov/pubmed/36637048
http://dx.doi.org/10.1002/ehf2.14272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192292/
https://www.ncbi.nlm.nih.gov/pubmed/36637048
http://dx.doi.org/10.1002/ehf2.14272

Ejemplares similares